These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28388569)
1. Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. Chang I; Mitsui Y; Kim SK; Sun JS; Jeon HS; Kang JY; Kang NJ; Fukuhara S; Gill A; Shahryari V; Tabatabai ZL; Greene KL; Dahiya R; Shin DM; Tanaka Y Oncotarget; 2017 Jun; 8(24):39087-39100. PubMed ID: 28388569 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer. Zhang X; Wang Y; Ning Y Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181 [TBL] [Abstract][Full Text] [Related]
3. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. Mitsui Y; Chang I; Fukuhara S; Hiraki M; Arichi N; Yasumoto H; Hirata H; Yamamura S; Shahryari V; Deng G; Wong DK; Majid S; Shiina H; Dahiya R; Tanaka Y BMC Cancer; 2015 Dec; 15():942. PubMed ID: 26626260 [TBL] [Abstract][Full Text] [Related]
4. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis. Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer. Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682 [TBL] [Abstract][Full Text] [Related]
6. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance. Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells. Yuan Y; Xiao Y; Li Q; Liu Z; Zhang X; Qin C; Xie J; Wang X; Xu T Mol Med Rep; 2013 Aug; 8(2):419-24. PubMed ID: 23783575 [TBL] [Abstract][Full Text] [Related]
8. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. Saini S; Hirata H; Majid S; Dahiya R Cancer Res; 2009 Sep; 69(17):7038-45. PubMed ID: 19690133 [TBL] [Abstract][Full Text] [Related]
9. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y; Kyprianou N Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572 [TBL] [Abstract][Full Text] [Related]
10. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells. Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456 [TBL] [Abstract][Full Text] [Related]
12. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA. Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971 [TBL] [Abstract][Full Text] [Related]
13. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of FAM84B during prostate cancer progression. Wong N; Gu Y; Kapoor A; Lin X; Ojo D; Wei F; Yan J; de Melo J; Major P; Wood G; Aziz T; Cutz JC; Bonert M; Patterson AJ; Tang D Oncotarget; 2017 Mar; 8(12):19218-19235. PubMed ID: 28186973 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis. Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691 [TBL] [Abstract][Full Text] [Related]
16. α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship. Chen P; Wang S; Cao C; Ye W; Wang M; Zhou C; Chen W; Zhang X; Zhang K; Zhou W Bioorg Chem; 2021 Nov; 116():105295. PubMed ID: 34455300 [TBL] [Abstract][Full Text] [Related]
17. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer. Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862 [TBL] [Abstract][Full Text] [Related]
18. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934 [TBL] [Abstract][Full Text] [Related]
19. Mechanistic role of cytochrome P450 (CYP)1B1 in oxygen-mediated toxicity in pulmonary cells: A novel target for prevention of hyperoxic lung injury. Dinu D; Chu C; Veith A; Lingappan K; Couroucli X; Jefcoate CR; Sheibani N; Moorthy B Biochem Biophys Res Commun; 2016 Aug; 476(4):346-351. PubMed ID: 27235555 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1. Mao M; Wu Z; Chen J Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]